You're reading the free version. Trader adds the live tape and alerts.
Start tracking
FENC Exercise Disclosure
Andrade Robert · SEC Form 4 · Filed Aug 28, 2026
Exercise
Calculated transaction value
$0
Andrade Robert Chief Financial Officer
FENC
Transaction date
Aug 28, 2026
Public filing date
Aug 28, 2026
Filing lag
Filed same day
FENC daily price context
Close on/before transaction
$12.27
Aug 28, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Options on Common Shares
- Quantity / price
- 21,928 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001468308-26-000028
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$995.33K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Fennec Pharmaceuticals Inc. FENC | Exercise | Aug 28, 2026 | $111.83K |
| Fennec Pharmaceuticals Inc. FENC Current | Exercise | Aug 28, 2026 | $0 |
| Fennec Pharmaceuticals Inc. FENC | Sale | Aug 27, 2026 | $883.5K |